ClearMind Biomedical's Seed Round

ClearMind Biomedical raised a round of funding on June 23, 2015. Investors include Y Combinator.

ClearMind is making a medical device to treat hemorrhagic stroke. The company has a predicate clinical study in 198 patients showing 80% reduction in death rate and 70% reduction in complication rate.…

Articles about ClearMind Biomedical's Seed Round: